Evidence map›Paper›PMID 24998850›Full record

ArticleOncogene2015

Polyoma small T antigen triggers cell death via mitotic catastrophe.

A T Pores Fernando, S Andrabi, O Cizmecioglu, C Zhu, D M Livingston, J M G Higgins, B S Schaffhausen, T M Roberts

Open access · greenAbstract read
In one paragraph

Article in Oncogene, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

A T Pores Fernando1] Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA [2] Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
S AndrabiDepartment of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
O Cizmecioglu1] Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA [2] Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
C ZhuDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, USA.
D M LivingstonDepartment of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
J M G Higgins1] Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, USA [2] Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle-upon-Tyne, UK.
B S SchaffhausenDepartment of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA, USA.
T M Roberts1] Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA [2] Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Harvard University · USBrigham and Women's Hospital · USDana-Farber Cancer Institute · USTufts University · US

Funding

VIRAL ONCOPROTEIN PERTURBATION OF RB/E2F PATHWAYP01CA050661 · NCI · DANA-FARBER CANCER INSTITUTE · PI HAHN, WILLIAM C. · 1989 to 2013
$35.8M
PRODUCTS OF THE TRANSFORMING GENES OF POLYOMAVIRUSR01CA034722 · NCI · TUFTS UNIVERSITY BOSTON · PI SCHAFFHAUSEN, BRIAN S · 1985 to 2015
$6.0M
MOLECULAR MECHANISMS OF POLYOMA INDUCED TRANSFORMATIONR01CA030002 · NCI · DANA-FARBER CANCER INSTITUTE · PI ROBERTS, THOMAS M · 1985 to 2014
$5.8M
MOLECULAR MECHANISMS OF POLYOMA-INDUCED TRANSFORMATIONR37CA030002 · NCI · DANA-FARBER CANCER INSTITUTE · PI ROBERTS, THOMAS M · 1993 to 1999
–
PRODUCTS OF THE TRANSFORMING GENES OF POLYOMA VIRUSR37CA034722 · NCI · TUFTS UNIVERSITY BOSTON · PI SCHAFFHAUSEN, BRIAN S · 1991 to 1998
–
NCI NIH HHS CA30002NCI NIH HHS CA34722NCI NIH HHS CA50661NCI NIH HHS P01 CA050661NCI NIH HHS R01 CA030002NCI NIH HHS R01 CA034722NCI NIH HHS R37 CA030002
6 · The paper itself

Abstract

Polyoma small T antigen (PyST), an early gene product of the polyoma virus, has been shown to cause cell death in a number of mammalian cells in a protein phosphatase 2A (PP2A)-dependent manner. In the current study, using a cell line featuring regulated expression of PyST, we found that PyST arrests cells in mitosis. Live-cell and immunofluorescence studies showed that the majority of the PyST expressing cells were arrested in prometaphase with almost no cells progressing beyond metaphase. These cells exhibited defects in chromosomal congression, sister chromatid cohesion and spindle positioning, thereby resulting in the activation of the spindle assembly checkpoint. Prolonged mitotic arrest then led to cell death via mitotic catastrophe. Cell cycle inhibitors that block cells in G1/S prevented PyST-induced death. PyST-induced cell death that occurs during M is not dependent on p53 status. These data suggested, and our results confirmed, that PP2A inhibition could be used to preferentially kill cancer cells with p53 mutations that proliferate normally in the presence of cell cycle inhibitors.

Indexed as

3T3 CellsAnimalsAntigens, Viral, TumorApoptosisCell CycleCell Line, TumorG1 Phase Cell Cycle CheckpointsHeLa CellsHumansMiceMitosisM Phase Cell Cycle CheckpointsPolyomavirusPrometaphaseProtein Phosphatase 2Spindle ApparatusAntigens, Viral, TumorProtein Phosphatase 2Tumor Suppressor Protein p53

Identifiers

PMID24998850
PMCPMC4286542
OpenAlexW1965792432

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.